Bio-Path Holdings to Announce Third Quarter 2023 Financial Results on November 15, 2023

Rhea-AI Summary

Bio-Path Holdings, Inc. (NASDAQ: BPTH) to report Q3 financial results and business overview in live conference call and webcast

HOUSTON, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH) a biotechnology company leveraging its proprietary DNAbilize^® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced that it will host a live conference call and audio webcast on Wednesday, November 15, 2023 at 8:30 a.m. ET to report financial results for the third quarter ended September 30, 2023 and to provide a business overview.

To access the live conference call, please call (833) 630-1956 (domestic) or (412) 317-1837 (international) at least five minutes prior to the start time. A live audio webcast of the call will also be available on the Presentations section of the Company’s website, www.biopathholdings.com. An archived webcast will be available on the Bio-Path website approximately two hours after the event.

About Bio-Path Holdings, Inc.

Bio-Path is a biotechnology company developing DNAbilize®, a novel technology that has yielded a pipeline of RNAi nanoparticle drugs that can be administered with a simple intravenous transfusion. Bio-Path’s lead product candidate, prexigebersen (BP1001, targeting the Grb2 protein), is in a Phase 2 study for blood cancers, and BP1001-A, a drug product modification of prexigebersen, is in a Phase 1 study for solid tumors . The Company’s second product, BP1002, which targets the Bcl-2 protein, is being evaluated for the treatment of blood cancers and solid tumors, including lymphoma and acute myeloid leukemia. In addition, an IND application is expected to be filed for BP1003, a novel liposome-incorporated STAT3 antisense oligodeoxynucleotide developed by Bio-Path as a specific inhibitor of STAT3.

For more information, please visit the Company's website at http://www.biopathholdings.com. 

Contact Information:
                        
Investors

Will O’Connor
Stern Investor Relations
212-362-1200
will@sternir.com  

Doug Morris
Investor Relations
Bio-Path Holdings, Inc.
832-742-1369

 

FAQ

What is the purpose of the live conference call and webcast by Bio-Path Holdings, Inc. (BPTH)?

The company will report its financial results for the third quarter ended September 30, 2023 and provide a business overview.

When will the live conference call and webcast take place for Bio-Path Holdings, Inc. (BPTH)?

It will be on Wednesday, November 15, 2023 at 8:30 a.m. ET.

How can I access the live conference call by Bio-Path Holdings, Inc. (BPTH)?

You can call (833) 630-1956 (domestic) or (412) 317-1837 (international) at least five minutes prior to the start time, or access the live audio webcast on the company's website, www.biopathholdings.com.

Will there be an archived webcast available after the event for Bio-Path Holdings, Inc. (BPTH)?

Yes, an archived webcast will be available on the company's website approximately two hours after the event.